The short answer
Dense breast tissue looks white on a mammogram, the same color as cancer. It lowers how much mammography detects and modestly raises risk, and every US report now states your density.
FDA says about half of US women over 40 have dense breast tissue.
Density lowers detection. In women aged 40 to 49, mammography sensitivity falls from about 81 percent in non-dense breasts to about 63 percent in dense breasts; at ages 70 to 74 it falls from about 90 percent to about 57 percent.
Density is also an independent risk factor. FDA states that dense tissue also raises the risk of developing breast cancer.
Since September 2024, FDA rules require every US mammogram report to tell you whether your breasts are dense or not dense.
On this page
Watch: Your mammogram says 'dense breasts' — now what?
1 min 3 sec · Captioned · Dense breast tissue is normal — and what supplemental screening can and can't do.
Also on YouTube.
Educational only — this video explains general report language and is not medical advice. Only your care team can say what a result means for you.
Open this video's own page →Choose how you want to read this
The whole article, with every detail and caution.
This page is for anyone told their breasts are dense. It covers what density means, why it can hide cancer, and what extra imaging can and cannot do.
What the density letter means
Since September 2024, FDA rules require every mammogram report in the United States to tell you whether your breasts are dense or not dense. Many people got that letter for the first time recently, and read it as bad news about their health. It is not a diagnosis.
Breast density describes the mix of tissue visible on the image. FDA's report uses four categories:
- Almost entirely fatty
- Scattered areas of fibroglandular density
- Heterogeneously dense, which may hide small masses
- Extremely dense, which lowers the sensitivity of mammography
The last two are what the word dense refers to. FDA says about half of US women over 40 have dense tissue.
Why it matters twice
Dense tissue creates two separate problems. They get blurred together constantly.
It hides cancer. On a mammogram, fat is dark and tumors are white. Dense fibroglandular tissue is also white. A cancer sitting inside it can be effectively invisible, the way a snowball is invisible against snow. This is called masking, and the numbers are substantial. In the AHRQ evidence review, sensitivity (how often the test finds a cancer that is there) in women aged 40 to 49 fell from 81.2 percent in non-dense breasts to 63.3 percent in dense breasts. At ages 70 to 74 the drop was steeper, from 90.0 percent to 57.1 percent.
It raises risk on its own. Dense tissue is also more likely to develop cancer, whatever the mammogram can see. FDA's notice says dense tissue raises the risk of developing breast cancer. Talk with your provider about what that means given your other risk factors.
The cancers that get missed
A cancer diagnosed after a normal mammogram, and before the next scheduled one, is called an interval cancer. In the Dutch DENSE trial, women with extremely dense breasts screened with mammography alone had an interval cancer rate of 5.0 per 1,000 screenings. That is the concrete shape of the masking problem.
It is worth holding two things at once. Reduced sensitivity is not zero sensitivity. Mammography still finds most breast cancers in dense breasts. And the USPSTF recommends screening every other year from 40 to 74.
What extra imaging does and costs
The DENSE trial randomized women with extremely dense breasts to supplemental MRI or to mammography alone. MRI cut the interval cancer rate from 5.0 to 2.5 per 1,000 screenings. It also produced 79.8 false positives per 1,000 screenings. That means most women called back because of the MRI did not have cancer, and many had a biopsy to establish that.
That is the whole trade in two sentences. Fewer cancers surface between screens. Considerably more people go through workups that end in nothing.
The USPSTF concluded that the evidence is insufficient to assess the balance of benefits and harms of supplemental ultrasound or MRI in women with dense breasts. It issued an I statement. An I statement means unknown, not no. It reflects that no trial has yet shown supplemental imaging reduces breast cancer deaths, which is a higher bar than reducing interval cancers.
Questions to work through with your care team
It helps to know which of the four categories you are in. Heterogeneously dense and extremely dense are not equivalent, and the evidence for supplemental MRI is strongest in the extremely dense group. A formal risk estimate is also useful. It should look at more than density alone.
It is worth checking coverage before scheduling. Ask your insurer whether supplemental imaging is covered for you.
The basic rule still applies. A lump, a change in skin or nipple, or focal pain that persists should be checked promptly, on its own. It does not matter how recently a mammogram was read as normal.
Sources
Common questions
My report says I have dense breasts. Is that a disease?
No. Breast density is a description of what your tissue looks like on a mammogram, not a diagnosis or an abnormality. Dense breasts have proportionally more fibrous and glandular tissue and less fat. It is common. FDA says about half of US women over 40 have dense tissue.
Why does density make cancer harder to see?
It is a contrast problem. Fat appears dark on a mammogram and tumors appear white, so a cancer in fatty tissue stands out. Dense fibroglandular tissue is also white, so a tumor sitting inside it can be hidden the way a snowball is hidden against snow. This is called masking, and it is why sensitivity drops as density rises rather than because the cancers themselves are different.
Should I get an ultrasound or MRI in addition to my mammogram?
There is no single right answer yet, which is what the USPSTF I statement means. Supplemental MRI clearly finds additional cancers and reduced interval cancers by half in the DENSE trial, but it also produced about 80 false positives per 1,000 screenings, most leading to further imaging or biopsy. Whether that trade is worth it depends on your density category, your other risk factors, your tolerance for false alarms, and what your insurance covers. It is a decision to make with your clinician rather than by rule.
Does having dense breasts mean a cancer found later will be worse?
This page could not confirm an answer in an approved source. What FDA says is that dense tissue makes cancer harder to see on a mammogram and also raises the risk of developing it. Ask your care team what your density means for you.
Should I stop having mammograms if they miss cancers in dense tissue?
No. Reduced sensitivity is not zero sensitivity, and mammography still finds the majority of cancers in dense breasts. The USPSTF recommends mammography every other year from 40 to 74, dense breasts or not. Density is a reason to ask about adding to your screening, not a reason to drop it.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-07-30 what this meansLast updated: 2026-10-02Next planned review: 2027-01-30
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.